COMPARISON OF INTRAOPERATIVE LOCAL ANESTHETIC APPLICATIONS IN POSTOPERATIVE PAIN MANAGEMENT IN LAPAROSCOPIC CHOLECYSTECTOMY PATIENTS
COMPARISON OF INTRAOPERATIVE TRANSVERSUS ABDOMINIS PLANE BLOCK, LOCAL ANESTHESIA APPLICATION TO THE PORT SITES AND INTRAPERITONEAL LOCAL ANESTHETIC APPLICATIONS IN POSTOPERATIVE PAIN MANAGEMENT IN LAPAROSCOPIC CHOLECYSTECTOMY PATIENTS
1 other identifier
interventional
3
1 country
1
Brief Summary
Since 1987, laparoscopic cholecystectomy has become the standard procedure for gallbladder stones and lesions. Complications due to improvements in laparoscopy and increased surgical experience have decreased day by day, but there is still a problem in terms of postoperative pain management. Several pain management procedures have been tried to combat pain after laparoscopic cholecystectomy. The aim of this study is to decrease the length of hospital stay, to increase the comfort of the patient and to reduce the cost of treatment. Local anesthetic injection to port locations, intraperitoneal periportal local anesthetic injection ,Transversus Abdominis Plane Blok and without any local anesthetic application to the control group compared to the group's analgesic efficiency and to reduce the amount of analgesics needed, shorten the length of hospital stay and improve patient comfort.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4 postoperative-pain
Started Nov 2018
Typical duration for phase_4 postoperative-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2018
CompletedFirst Submitted
Initial submission to the registry
December 15, 2018
CompletedFirst Posted
Study publicly available on registry
December 31, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2021
CompletedMarch 23, 2021
March 1, 2021
2.1 years
December 15, 2018
March 19, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Level of postoperative pain: visual analogue scale
the level of the pain will be assessed using the VAS ( visual analogue scale) which is a psychometric response scale and the patient has to indicate a position along a continuous line between two end-points (no pain and maximum pain) that best reflects the intensity of their pain. The pain measurements will be done at 1,2,4,6,12,24 hours. Test is easy to obtain, reliable, valid and can detect changes of over time
24 hours
Study Arms (4)
Transversus Abdominis Plane Block
ACTIVE COMPARATORTransversus abdominis plane block (10 cc / 10 cc, 0.5% bupivacaine to the right and left transversus abdominis muscle regions) will be applied.
TROCHAR SITES LOCAL ANESTHETIC INJECTION
ACTIVE COMPARATORlocal anesthetic injection (6 cc to subxiphoid and infraumbilical trocar sites, 4 cc instead of 2 cc, 0.5% bupivacaine solution to be applied)
INTRAPERİTONEAL LOCAL ANESTHETIC SPREADING METHOD
ACTIVE COMPARATORIntraperitoneal direct vision of the gallbladder excision area-periportal area under the direct injection of local anesthetic spraying process (percutaneous method injected into the periportal area 1: 1 diluted with 20 cc SF, 20 cc 0.5% bupivacaine solution total 40 cc spraying will be applied.
CONTROL GROUP
NO INTERVENTIONgroup will be the control group and any of these methods will not be applied,
Interventions
In our study this local anesthetic agent will be applied for postoperative pain relief
Eligibility Criteria
You may qualify if:
- Patients over 18 years of age who were admitted to the general surgery department with the diagnosis of cholelithiasis
You may not qualify if:
- Patients who need to undergo peroperative open cholecystectomy procedure.
- Patients with local anesthetic or NSAID allergy
- Patients in pregnancy
- Patients who are breastfeeding
- Patients with connective tissue disease
- Patients with malignancy in postoperative gallbladder pathological examination and patients with any malignancy diagnosis
- Patients with renal impairment, where the effect of using Marcain is unknown
- Cardiac disease
- Patients with hepatic impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fatih Sultan Mehmet Research and Training Hospital
Istanbul, 34734, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- asistant doctor
Study Record Dates
First Submitted
December 15, 2018
First Posted
December 31, 2018
Study Start
November 1, 2018
Primary Completion
December 1, 2020
Study Completion
March 1, 2021
Last Updated
March 23, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share